Page last updated: 2024-10-31

neostigmine and Smoking Cessation

neostigmine has been researched along with Smoking Cessation in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Smoking Cessation: Discontinuing the habit of SMOKING.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lagrue, G1
Cormier, S1
Mautrait, C1
Diviné, C1
Rose, JE1
Behm, FM1
Ramsey, C1
Ritchie, JC1

Trials

1 trial available for neostigmine and Smoking Cessation

ArticleYear
Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2001, Volume: 3, Issue:4

    Topics: Administration, Cutaneous; Adult; Female; Humans; Male; Mecamylamine; Monoamine Oxidase; Neostigmine

2001

Other Studies

1 other study available for neostigmine and Smoking Cessation

ArticleYear
[Stopping smoking and constipation].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 1

    Topics: Cholinesterase Inhibitors; Constipation; Female; Follow-Up Studies; Humans; Magnesium; Middle Aged;

2006